eXoZymes, Inc. (EXOZ)
4.30
+0.19
(+4.62%)
USD |
NASDAQ |
Nov 06, 10:14
eXoZymes Total Liabilities (Quarterly) : 4.328M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.328M |
| March 31, 2026 | 2.491M |
| December 31, 2025 | 2.574M |
| September 30, 2025 | 2.345M |
| June 30, 2025 | 2.441M |
| March 31, 2025 | 2.644M |
| Date | Value |
|---|---|
| December 31, 2024 | 2.614M |
| September 30, 2024 | 7.162M |
| June 30, 2024 | |
| December 31, 2023 | 3.943M |
| December 31, 2022 | 1.313M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| MiMedx Group, Inc. | 53.47M |
| ABVC BioPharma, Inc. | 7.131M |
| Endonovo Therapeutics, Inc. | 30.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.982M |
| Shareholders Equity (Quarterly) | 3.654M |
| Debt to Equity Ratio | 0.2969 |
| Current Ratio | 3.813 |
| Net Debt Paydown Yield | 0.06% |